Summit Therapeutics Reports Financial Results For The Second Quarter And Half Year Ended 31 July 2017 And Operational Progress Post author:Sam Post published:August 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Mauna Kea Technologies: Cellvizio Now CE Marked For Use During Robotic-Assisted Surgery October 9, 2017 Investment Group Just Paid $605 Million for This Bay Area Pharma June 7, 2017 Ignyta Reports Granting Of Inducement Awards September 17, 2017
Mauna Kea Technologies: Cellvizio Now CE Marked For Use During Robotic-Assisted Surgery October 9, 2017